Laws & Regulations
A comprehensive database of drug regulations, guidelines, and standards in China.
-
ChinaMedical Device Administration Law (Draft for Comments)医疗器械管理法（草案征求意见稿）DraftType: LawRelease Date: 2024-08-28Implementation Date: /
-
ChinaGuidance for On-site Inspection of Drug Marketing Authorization Holders (MAHs)' Outsourced Manufacturing国家药监局综合司关于印发药品上市许可持有人委托生产现场检查指南的通知In forceType: GuidelineRelease Date: 2023-10-24Implementation Date: 2023-10-24
-
ChinaNotice on Enhancing the Supervision and Management of Outsourced Manufacturing for Drug Marketing Authorization Holders (MAHs) (No. 132, 2023)国家药监局关于加强药品上市许可持有人委托生产监督管理工作的公告（2023年第132号）In forceType: NoticeRelease Date: 2023-10-23Implementation Date: 2023-10-23
-
ChinaNotice on the Administration of Chemical Active Pharmaceutical Ingredient (API) Registration Renewal国家药监局关于化学原料药再注册管理等有关事项的公告（2023年第129号）In forceType: NoticeRelease Date: 2023-10-13Implementation Date: 2023-10-13
-
ChinaNotice on Studies on Generic Drugs Without Reference Listed Drugs (RLDs)国家药监局关于无参比制剂品种仿制研究的公告（2023年第130号）In forceType: NoticeRelease Date: 2023-10-13Implementation Date: 2023-10-13
-
ChinaIn forceType: GuidelineRelease Date: 2023-10-13Implementation Date: 2023-10-13
-
ChinaIn forceType: GuidelineRelease Date: 2023-10-13Implementation Date: 2023-10-13
-
ChinaFAQs on the Administration of Human Genetic Resources关于发布人类遗传资源管理常见问题解答的通知In forceType: Q&ARelease Date: 2023-09-12Implementation Date: 2023-09-12
-
ChinaIn forceType: RegulationRelease Date: 2023-07-21Implementation Date: 2023-07-21
-
ChinaNotice of NMPA on Regulating the Display of Prescription Drug Online Sales Information国家药监局综合司关于规范处方药网络销售信息展示的通知In forceType: NoticeRelease Date: 2023-06-20Implementation Date: 2023-06-20
Most Popular
- Chinese Pharmacopoeia 2020 Edition
- Chinese Pharmacopoeia 9012 Guidelines for Validation of Quantitative Analytical Method of Biological Samples
- Drug Administration Law of the People's Republic of China (2nd Revision)
- Chinese Pharmacopoeia 9001 Guidelines for the Stability Testing of Drug Substances and Preparations
- Guidance for On-site Inspection of Drug Marketing Authorization Holders (MAHs)' Outsourced Manufacturing